UBS Group’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History
Bought
Maintained
Sold
Other funds holding HEAL
WWM
PCA
IWM
FFA
UBS Group's HEAL Position: Q1 2026 in Review
UBS Group sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q1 2026, closing a stake of 57 shares — an estimated $1.67K sold.
UBS Group first reported a position in HEAL in Q4 2020 and held it in 21 quarters. The position peaked at $5.57M in Q1 2021. 30 funds tracked by Wall St. Rank hold HEAL as of Q1 2026.
- UBS Group reported no remaining Global X Funds Global X HealthTech ETF position as of Q1 2026 after selling out during the quarter.
- UBS Group sold 57 Global X Funds Global X HealthTech ETF shares in Q1 2026, an estimated $1.67K.
- UBS Group first reported a position in Global X Funds Global X HealthTech ETF in Q4 2020 and held it in 21 quarters.
- UBS Group's Global X Funds Global X HealthTech ETF position peaked at $5.57M in Q1 2021.
- 30 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.